Chloroprocaine Hydrochloride Injection, Solution
NDC Package 84549-209-10
Package Information
Chloroprocaine Hydrochloride injection is 2% and 3%, in single dose vials, without methylparaben preservative, without EDTA, is indicated for the production of local anesthesia by infiltration, peripheral and central nerve block, including lumbar and caudal epidural blocks.Chloroprocaine hydrochloride injection is not to be used for subarachnoid administration. This formulation utilizes a injection, solution delivery system. Marketed by Propharma Distribution, this product is identified by NDC 84549-209 and is authorized under FDA application ANDA040273.
Identification & Billing
- RxCUI: 1794184 - chloroprocaine HCl 2 % in 20 ML Injection
- RxCUI: 1794184 - 20 ML chloroprocaine hydrochloride 20 MG/ML Injection
- RxCUI: 1794184 - chloroprocaine hydrochloride 2 % per 20 ML Injection
Clinical Specifications
- Epidural - Administration upon or over the dura mater.
- Infiltration - Administration that results in substances passing into tissue spaces or into cells.
- Intracaudal - Administration within the cauda equina.
- Perineural - Administration surrounding a nerve or nerves.
Regulatory & Marketing
Hierarchy Structure
- 84549 - Propharma Distribution
- 84549-209 - Chloroprocaine Hydrochloride
- 84549-209-10 - 20 mL in 1 VIAL
- 84549-209 - Chloroprocaine Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 84549-209-10 identifies a specific commercial package of 20 ml in 1 vial of Chloroprocaine Hydrochloride, a human prescription drug labeled by Propharma Distribution. This injection, solution is formulated for epidural; infiltration; intracaudal; perineural use and contains chloroprocaine hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Propharma Distribution on November 01, 1998. The current certification is valid through December 31, 2026.
How is this Propharma Distribution product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 84549020910. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.